News

Filter

1 to 9 of 97563 results

Baxter says record 2014 results set solid foundation for planned separation

29-01-2015

US drugmaker Baxter International today announced fourth quarter 2014 financial results that exceeded…

Baxter InternationalFinancialPharmaceutical

Australia: Foresight to translate research into treatments, devices and diagnostics

29-01-2015

Amid the growing realization that Australian research needs support to make it a reality, the Queensland…

AustraliaBiotechnologyFinancialResearch

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

29-01-2015

Results from the pivotal Phase III trial of Jakavi (ruxolitinib) carried out by Swiss drug major Novartis…

HematologyJakaviNovartisPharmaceuticalResearch

GSK and Novartis get European clearance for asset swap

GSK and Novartis get European clearance for asset swap

29-01-2015

UK pharma major GlaxoSmithKline has received clearance from the European Commission for its proposed…

EuropeFinancialGlaxoSmithKlineNovartisOncologyPharmaceuticalUK

AstraZeneca to employ CRISPR, a new technique for drug discovery

AstraZeneca to employ CRISPR, a new technique for drug discovery

29-01-2015

Anglo-Swedish pharma major AstraZeneca has announced a research program to develop new medicines that…

AstraZenecaBiologyBiotechnologyResearchUK

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

29-01-2015

Photodynamic technology specialist Photocure has published data on a retrospective study showing Hexvix…

BiotechnologyHexvixOncologyPhotocureResearch

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

29-01-2015

France-based biotech firm Valneva and UK company Immune Targeting Systems (ITS) have signed an exclusive…

Anti-viralsBiotechnologyGlobalImmune Targeting SystemsLicensingValneva

Rapid expansion forecast for global Cushing’s syndrome drug market

Rapid expansion forecast for global Cushing’s syndrome drug market

29-01-2015

The global Cushing’s syndrome (CS) treatment market will expand rapidly in value from around $179 million…

CortendoEuropeHRA PharmaKetoconazoleMarkets & MarketingMetabolicsNormoCortNovartisPharmaceuticalRare diseasesSigniforUSA

1 to 9 of 97563 results

Back to top